Articles tagged "Kidney/pancreas transplantation"

2015 American Transplant Congress
Donor Obesity Impact on Simultaneous Kidney-Pancreas Transplantation Outcomes
T. Alhamad,¹ A. Malone,¹ H. Chakkera.²
¹Transplantation Nephrology, Renal Division, Washington University, St Louis; ²Renal Division, Mayo Clinic, Phoenix, AZ.
Background: Donor obesity has been reported as a risk factor for early pancreas allograft failure. The relationship between donor obesity and long-term pancreas allograft survival…
2015 American Transplant Congress
The Impact of Center Volume on Simultaneous Kidney-Pancreas Transplantation Outcomes
A. Malone,¹ D. Brennan,¹ J. Wellen,² T. Alhamad.¹
¹Transplantation Nephrology, Renal Division, Washington University, St Louis; ²Section of Transplant Surgery, Washington University, St Louis.
Background: Pancreas transplantation is associated with a high incidence of surgical complications and successful outcomes require experienced surgical and post-transplant care. Prior studies have linked…
2015 American Transplant Congress
Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?
J. Harbell,¹ T. Morgan,² V. Feldstein,² G. Roll,¹ A. Posselt,¹ S.-M. Kang,¹ S. Feng,¹ R. Hirose,¹ C. Freise,¹ P. Stock.¹
¹Surgery, University of California, San Francisco, San Francisco, CA; ²Radiology, University of California, San Francisco, San Francisco, CA.
Background: Prophylaxis for graft portal/splenic venous thrombosis following pancreas transplant varies between institutions. Similarly, treatment of venous thrombosis ranges from early re-exploration to conservative management…
2015 American Transplant Congress
Sirolimus Based Maintenance Immunosuppression in Pancreas Transplant Recipients
A. Rajab, R. Pelletier, E. Elkhammas, G. Bumgardner, A. El-Hinnawi, M. Henry.
Surgery, The Ohio State University, Columbus, OH.
The present study evaluated the outcome of a Sirolimus based maintenance immunosuppressive protocol in pancreas transplant recipients. Between August 2003 and December 2013, a total…
2015 American Transplant Congress
Safety and Efficacy of Conversion from Conventional Twice Daily Tacrolimus to Once Daily Extended Release Tacrolimus in Stable Pancreas Transplant (SPK and PAK) Recipients
M. Dib, A. Barbas, M. Marquez, J. Laurence, G. Sapisochin, A. Norgate, J. Schiff, I. McGilvray, P. Greig, M. Selzner, M. Cattral.
Surgery, Multi-Organ Transplant, Toronto General Hospital, Toronto, ON, Canada.
Background: A once-daily, modified-release oral formulation of tacrolimus has been developed to simplify dosing and improve medication adherence. There is limited data on the implementation…
2015 American Transplant Congress
Donors at Age Extremes for Simultaneous Pancreas-Kidney Transplant (SPKT)
A. El-Hinnawi, R. Pelletier, E. Elkhammas, A. Rajab, G. Bumgardner, R. Plews, T. Pesavento, U. Nori, M. Henry.
The Comprehensive Transplant Center (CTC), The Ohio State University College of Medicine, Columbus, OH.
Background:Shortage of optimal pancreatic donors stimulates a search for options to expand the donor pool. Extreme age donors ( <13 yrs or > 50 yrs…